ALLE vs STRL

ALLE's Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a definitive distress risk assessment. The company trades above its Graham Number of $61.34 at a current price of $166.80, reflecting a significant premium, though justified in part by solid profitability metrics including a 36.41% ROE and consistent earnings growth. Despite strong historical earnings surprises and solid margins, elevated valuation multiples and bearish insider activity temper upside potential. Analysts concur with a 'hold' recommendation, aligning with the neutral stance.

STRL exhibits a stable financial foundation with a Piotroski F-Score of 6/9 and a very healthy Debt/Equity ratio of 0.32. However, there is a massive divergence between the current market price ($463.65) and deterministic value markers, with a Graham Number of $87.27 and an Intrinsic Value of $65.59. While revenue growth is explosive at 51.5% and the company has a stellar track record of earnings beats, the valuation is stretched (P/B of 12.83) and insider sentiment is heavily bearish. The stock is currently a high-growth momentum play trading at a significant premium to its fundamental value.